2024 Gathering

Program Agenda
TimeActivity
8 a.m.

Welcome & End Lung Cancer Now Year in Review
MacKenzie Church, End Lung Cancer Now

8:20 a.m.

Current State of Lung Cancer
Nasser Hanna, MD

8:30 a.m.

Lung Cancer Research: A Patient’s Perspective
Jill Feldman
Co-founder, EGFR Resisters
2024 ASCO Patient Advocate Award Recipient

8:50 a.m.

Behind the Scenes with a Lung Cancer Researcher
Eric Singhi, MD
Assistant Professor, Department of General Oncology
MD Anderson Cancer Center

9:10 a.m.

Implementation of Clinical Trials
Brian Stemme
CEO, Hoosier Cancer Research Network

9:30 a.m.

Focus Group Overview
MacKenzie Church, End Lung Cancer Now

9:40 a.m.Break / Exhibits & Vendors
10 a.m.Focus Groups: Refining the Research Toolkit
11:35 a.m.Break / Exhibits & Vendors
12 p.m.Lunch
12:30 p.m.Lung Cancer Survivor Story
12:50 p.m.Adjourn / Exhibits & Vendors

Featured Speakers

Jill Feldman

Lung Cancer Patient and Advocate
Co-Founder EGFR Resisters

Jill Feldman is a lung cancer patient and advocate. With an extensive family history of lung cancer, Jill got involved in lung cancer advocacy in 2001, when it was in its infancy. In 2009, at 39 years old with four small children, Jill herself was diagnosed with EGFR-positive lung cancer.

Jill is committed to understanding and promoting patient-centered research as past chair of the International Association for the Study of Lung Cancer’s patient advisory board, a member of the programmatic panel for the Department of Defense Lung Cancer Research Program, a member of the ECOG-ACRIN Research Group’s patient advocate committee and thoracic committee, and as the patient advocate on the National Lung Cancer Round Table steering committee. In addition, she is a co-founder of the EGFR Resisters, a grassroots, patient-driven community committed to accelerating research that will pro-long and better the lives of people diagnosed with EGFRm-positive lung cancer.

Jill serves in various other leadership roles to improve the speed and quality of research and use her voice and privilege to embed a health equity lens in all aspects of research and care. She is passionate about advocating for the critical aspects of the lived experience, including the physical, psychosocial, logistical, and financial effects of cancer and treatment on patients and families.

Eric Singhi, MD

Assistant Professor, Department of General Oncology
MD Anderson Cancer Center

Dr. Eric K. Singhi is an assistant professor and thoracic medical oncologist at the University of Texas MD Anderson Cancer Center. He completed his internal medicine residency at Vanderbilt University and served as chief hematology/oncology fellow at MD Anderson during his training. Dr. Singhi specializes in patient education research, and the care and research of young patients with lung cancer. Additionally, within MD Anderson Cancer Center, he serves as the patient safety and quality officer for the Thoracic/Head and Neck Medical Oncology Department, and as co-director of the thoracic medical oncology rotation for the medical oncology fellowship program.

All Star

#ResearchCuresCancer

Support Our Research